- Doctors Describe Texas Dairy Farm Worker’s Case of Bird Flu
- Does Preschool Boost Kids’ Long-Term Academic Success? Study Finds Mixed Results
- AI Might Spot Rare Diseases in Patients Years Earlier
- An Orangutan Healed Himself With Medicinal Plant
- Quit-Smoking Meds Not Working for You? Try Upping the Dose
- Fewer Americans Are Suffering Most Dangerous Form of Heart Attack
- Even Skipping Meat for One Meal Helps Liver Disease Patients
- You May Not Have to Fast Before Catheter-Based Heart Test, Study Suggests
- EPA Earmarks $3 Billion to Replace Lead Pipes Nationwide
- Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
First Device to Treat Migraine With Aura Approved
The first device to treat migraine pain when the headache is preceded by an often-visual disturbance called an aura has been approved by the U.S. Food and Drug Administration.
The Cerena Transcranial Magnetic Stimulator (TMS) is held to the back of the head and the user presses a button to release a pulse of magnetic energy. This stimulates the brain’s occipital cortex, which may reduce or eliminate migraine-associated pain, the FDA said in a news release.
The device was tested in a clinical trial of 201 people with mostly moderate-to-strong migraines. Nearly 38 percent of people with migraine pain were pain-free two hours after use, compared with 17 percent of people who didn’t use the device, the FDA said. The device was not evaluated among people with headaches other than those with migraines preceded by aura, the agency said.
Among the rare side effects reported were sinusitis and dizziness. The device shouldn’t be used by people with metals in the head, neck or upper body, or by people with an implanted medical device such as a pacemaker or deep brain stimulator, the FDA said.
The Cerena TMS is produced by eNeura Therapeutics, based in Sunnyvale, Calif.
More information
The FDA has more about this approval.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.